# OnCo record zuma-2 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/zuma-2/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "zuma-2", "NCT02601313" ;
  schema:name "ZUMA-2"@en ;
  schema:description "ZUMA-2 showed that CD19 CAR-T cells could produce deep and lasting remissions in mantle cell lymphoma that had stopped responding to BTK inhibitors, a group that previously had few options."@en ;
  schema:url <https://onco.cc/trials/zuma-2/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02601313> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/mantle-cell-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/brexucabtagene-autoleucel/> ;
  onco:companies <https://onco.cc/companies/gilead/> ;
  onco:people <https://onco.cc/people/michael-wang/> .